首页> 外文期刊>Journal of chromatography, A: Including electrophoresis and other separation methods >Microextraction by packed sorbent and high performance liquid chromatography determination of seven non-steroidal anti-inflammatory drugs in human plasma and urine
【24h】

Microextraction by packed sorbent and high performance liquid chromatography determination of seven non-steroidal anti-inflammatory drugs in human plasma and urine

机译:填充吸附剂微萃取-高效液相色谱法测定人血浆和尿液中的七种非甾体类抗炎药

获取原文
获取原文并翻译 | 示例
       

摘要

This paper reports a new MEPS-HPLC-PDA method for the simultaneous analysis of seven non-steroidal anti-inflammatory drugs (Furprofen, Indoprofen, Ketoprofen, Fenbufen, Flurbiprofen, Indomethacin, and Ibuprofen) in human plasma and urine. NSAIDs were resolved on a Gemini C_(18) column (4.6 mm × 250 mm; 5 μm particle size) using a gradient elution mode with a run time of 25 min, comprising re-equilibration, without further purification. The method was validated over the concentration range from 0.1 to 10 μg/mL for all the analytes both in human plasma and urine, using Benzyl 4-hydroxybenzoate as the internal standards. This method was successfully tested to NSAIDs analyses in real matrices, in order to check the method potentiality and the correct response. The results from assay validations show that the method is selective, sensitive and robust. The limit of quantification of the method was 0.1 μg/mL for all analytes, and weighted-matrix-matched standard curves showed a good linearity up to 10 μg/mL. In order to check the correct response for over-range samples, parallelism tests were also assessed. In the entire analytical range the intra and inter-day precision (RSD%) values were ≤7.31% and ≤13.5%, respectively. For all the analytes the intra and inter-day trueness (Bias%) values ranged from ?11.3% to 10.2%. To our knowledge, this is the first MEPS-HPLC-PDA based method that uses MEPS procedure for simultaneous determination of these seven NSAIDs in plasma and urine samples.
机译:本文报道了一种新的MEPS-HPLC-PDA方法,用于同时分析人血浆和尿液中的7种非甾体类抗炎药(氟洛芬,吲哚洛芬,酮洛芬,芬布芬,氟比洛芬,吲哚美辛和布洛芬)。 NSAIDs在Gemini C_(18)色谱柱(4.6 mm×250 mm; 5μm粒径)上使用梯度洗脱模式进行分离,运行时间为25分钟,包括重新平衡,无需进一步纯化。使用4-羟基苯甲酸苄酯作为内标,该方法在人血浆和尿液中所有分析物的浓度范围为0.1至10μg/ mL时均得到验证。该方法已在真实矩阵中成功通过NSAIDs分析测试,以检查该方法的潜力和正确的响应。分析验证的结果表明,该方法具有选择性,灵敏性和鲁棒性。对于所有分析物,该方法的定量限为0.1μg/ mL,加权矩阵匹配的标准曲线显示高达10μg/ mL的良好线性。为了检查超范围样本的正确响应,还评估了并行度测试。在整个分析范围内,日内和日间精度(RSD%)值分别≤7.31%和≤13.5%。对于所有分析物,日内和日间真实性(Bias%)值的范围为?11.3%至10.2%。据我们所知,这是第一个基于MEPS-HPLC-PDA的方法,该方法使用MEPS程序同时测定血浆和尿液样品中的这7种NSAID。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号